(E)-3-[4-[1-(2-hydroxyethyl)pyrazol-4-yl]-3-pyridinyl]-N-[4-[2-(1,3,4-oxadiazol-2-yl)ethyl]phenyl]prop-2-enamide

C23H22N6O3 — CID 126568460

IUPAC(E)-3-[4-[1-(2-hydroxyethyl)pyrazol-4-yl]-3-pyridinyl]-N-[4-[2-(1,3,4-oxadiazol-2-yl)ethyl]phenyl]prop-2-enamide
SMILESO=C(/C=C/c1cnccc1-c1cnn(CCO)c1)Nc1ccc(CCc2nnco2)cc1
InChIInChI=1S/C23H22N6O3/c30-12-11-29-15-19(14-26-29)21-9-10-24-13-18(21)4-7-22(31)27-20-5-1-17(2-6-20)3-8-23-28-25-16-32-23/h1-2,4-7,9-10,13-16,30H,3,8,11-12H2,(H,27,31)/b7-4+
InChIKeyQAKMMNCNZBKLJJ-QPJJXVBHSA-N
MW430.47 g/mol
LogP2.76
Rot. Bonds9

About (E)-3-[4-[1-(2-hydroxyethyl)pyrazol-4-yl]-3-pyridinyl]-N-[4-[2-(1,3,4-oxadiazol-2-yl)ethyl]phenyl]prop-2-enamide

(E)-3-[4-[1-(2-hydroxyethyl)pyrazol-4-yl]-3-pyridinyl]-N-[4-[2-(1,3,4-oxadiazol-2-yl)ethyl]phenyl]prop-2-enamide (PubChem CID 126568460) has the molecular formula C23H22N6O3 and a molecular weight of 430.47 g/mol. Its IUPAC name is (E)-3-[4-[1-(2-hydroxyethyl)pyrazol-4-yl]-3-pyridinyl]-N-[4-[2-(1,3,4-oxadiazol-2-yl)ethyl]phenyl]prop-2-enamide.

Molecular Properties

Compound Name(E)-3-[4-[1-(2-hydroxyethyl)pyrazol-4-yl]-3-pyridinyl]-N-[4-[2-(1,3,4-oxadiazol-2-yl)ethyl]phenyl]prop-2-enamide
PubChem CID126568460
Molecular FormulaC23H22N6O3
Molecular Weight430.47 g/mol
Exact Mass430.18
IUPAC Name(E)-3-[4-[1-(2-hydroxyethyl)pyrazol-4-yl]-3-pyridinyl]-N-[4-[2-(1,3,4-oxadiazol-2-yl)ethyl]phenyl]prop-2-enamide
SMILESO=C(/C=C/c1cnccc1-c1cnn(CCO)c1)Nc1ccc(CCc2nnco2)cc1
InChIInChI=1S/C23H22N6O3/c30-12-11-29-15-19(14-26-29)21-9-10-24-13-18(21)4-7-22(31)27-20-5-1-17(2-6-20)3-8-23-28-25-16-32-23/h1-2,4-7,9-10,13-16,30H,3,8,11-12H2,(H,27,31)/b7-4+
InChIKeyQAKMMNCNZBKLJJ-QPJJXVBHSA-N
XLogP2.76
TPSA118.96 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds9
Heavy Atoms32
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500430.47
LogP ≤ 52.76
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (E)-3-[4-[1-(2-hydroxyethyl)pyrazol-4-yl]-3-pyridinyl]-N-[4-[2-(1,3,4-oxadiazol-2-yl)ethyl]phenyl]prop-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (E)-3-[4-[1-(2-hydroxyethyl)pyrazol-4-yl]-3-pyridinyl]-N-[4-[2-(1,3,4-oxadiazol-2-yl)ethyl]phenyl]prop-2-enamide?
The IUPAC name of (E)-3-[4-[1-(2-hydroxyethyl)pyrazol-4-yl]-3-pyridinyl]-N-[4-[2-(1,3,4-oxadiazol-2-yl)ethyl]phenyl]prop-2-enamide (CID 126568460) is (E)-3-[4-[1-(2-hydroxyethyl)pyrazol-4-yl]-3-pyridinyl]-N-[4-[2-(1,3,4-oxadiazol-2-yl)ethyl]phenyl]prop-2-enamide.
What is the SMILES notation for (E)-3-[4-[1-(2-hydroxyethyl)pyrazol-4-yl]-3-pyridinyl]-N-[4-[2-(1,3,4-oxadiazol-2-yl)ethyl]phenyl]prop-2-enamide?
The canonical SMILES for (E)-3-[4-[1-(2-hydroxyethyl)pyrazol-4-yl]-3-pyridinyl]-N-[4-[2-(1,3,4-oxadiazol-2-yl)ethyl]phenyl]prop-2-enamide is O=C(/C=C/c1cnccc1-c1cnn(CCO)c1)Nc1ccc(CCc2nnco2)cc1.
What is the InChIKey of (E)-3-[4-[1-(2-hydroxyethyl)pyrazol-4-yl]-3-pyridinyl]-N-[4-[2-(1,3,4-oxadiazol-2-yl)ethyl]phenyl]prop-2-enamide?
The InChIKey is QAKMMNCNZBKLJJ-QPJJXVBHSA-N. The full InChI is InChI=1S/C23H22N6O3/c30-12-11-29-15-19(14-26-29)21-9-10-24-13-18(21)4-7-22(31)27-20-5-1-17(2-6-20)3-8-23-28-25-16-32-23/h1-2,4-7,9-10,13-16,30H,3,8,11-12H2,(H,27,31)/b7-4+.
What are the key properties of (E)-3-[4-[1-(2-hydroxyethyl)pyrazol-4-yl]-3-pyridinyl]-N-[4-[2-(1,3,4-oxadiazol-2-yl)ethyl]phenyl]prop-2-enamide?
(E)-3-[4-[1-(2-hydroxyethyl)pyrazol-4-yl]-3-pyridinyl]-N-[4-[2-(1,3,4-oxadiazol-2-yl)ethyl]phenyl]prop-2-enamide has a molecular weight of 430.47 g/mol, XLogP of 2.76, 9 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-3-[4-[1-(2-hydroxyethyl)pyrazol-4-yl]-3-pyridinyl]-N-[4-[2-(1,3,4-oxadiazol-2-yl)ethyl]phenyl]prop-2-enamide is sourced from PubChem (CID 126568460), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).